- Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
-
Chan ATP, Tang SCW
- KMID: 2540197
- Kidney Res Clin Pract.
- 2022 Nov;41(6):682-698.
- doi: 10.23876/j.krcp.21.285
Progress in the treatment of diabetic kidney disease (DKD) has been modest since the early trials on renin-angiotensin-aldosterone system inhibitors (RAASis). Although sodium-glucose co-transporter 2 inhibitors (SGLT2is) have revolutionized the... -
- CITED
-
- Close
- SHARE
-
- Close
